NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
NHMRC Glaucoma Guidelines - ANZGIG
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA<br />
Chapter 9 – Medication<br />
Evidence Statements<br />
• Evidence strongly supports using topical medications as the simplest and safest first choice for<br />
glaucoma management.<br />
• Evidence strongly supports limiting the use of systemic medication to situations where patients cannot<br />
tolerate topical medications, are unable to safely and effectively instill topical medications, are failing to<br />
achieve intraocular pressure targets, or when laser therapy or surgery either had poor outcomes,<br />
or are contraindicated.<br />
• Evidence strongly supports using a topical prostaglandin analogue or beta-blocker in the initial<br />
management of glaucoma unless contraindicated.<br />
• Evidence strongly supports carbonic anhydrase inhibitors and alpha2-agonists as second and third<br />
choice medication management, with dosing regimens of two to three times daily.<br />
Facilitating adherence<br />
Optimum medication management of glaucoma requires a high level of adherence to medication<br />
administration. The largely asymptomatic, chronic and incurable nature of glaucoma is also<br />
responsible for significant non-adherence with treatment, as the adverse effects of not following<br />
a treatment plan are not severe (or are without immediate consequences in the short term)<br />
(EGS 2003). Despite the availability of effective medications, non-adherence in patients with glaucoma<br />
has been reported to vary from 24% to 59% (Tsai 2006 citing Rotchford 1998; American Academy of<br />
Ophthalmology [AAO] 2005a; South African <strong>Glaucoma</strong> Society [SAGS] 2006). Adherence is influenced<br />
by the frequency of topical medication (drop) instillation, side effects, cost and lack of understanding<br />
of the disease process (SAGS 2006).<br />
Patient education and informed participation in treatment decisions improves adherence as well as<br />
the overall effectiveness of medication management (Osterberg & Blaschke 2005). Patient involvement<br />
is recommended as best practice for the management of other chronic diseases (Holman & Lorig<br />
2000; Lorig, Sobel, Stewart et al 1999; Lorig, Holman, Sobel et al 2000). The literature reviewed for<br />
these guidelines consistently endorsed that health care providers should develop patient-by-patient<br />
understanding of the factors that may constrain their adherence with glaucoma management strategies.<br />
Health care providers should then develop strategies to address patient-specific barriers to optimise<br />
patient adherence to management programs. Understanding patients’ social and behavioural responses<br />
to the diagnosis of a chronic eye condition such as glaucoma is essential for health care providers<br />
to assist them to manage their condition in the best possible manner. Management strategies should<br />
aim to optimise quality of life, and reduce complications whilst decreasing deterioration of the<br />
condition. Self-management strategies that engage patients in their own care are successful compared<br />
with health-professional-directed ‘paternalistic’ care (Nys 2008). Potentially simple, patient-centred<br />
approaches are the most effective long-term strategies for effective glaucoma management.<br />
To maximise patient adherence with medication, health care providers are advised to simplify the<br />
medication regimen wherever possible. The lowest dose of the most effective medication should<br />
be used for each patient in order to reach the target IOP and prevent progression of structural<br />
damage and VF defects. A once-daily medication dose appears to increase patient satisfaction and<br />
adherence can be improved through the use of combination eye drops (Tsai 2006 citing Stewart<br />
2004). Many pharmacies have the capacity to provide a medicines profile, listing the prescription,<br />
OTC and complementary medicines being taken by a particular patient. The profiles are used to<br />
support patients in managing their medicines and can also be used as an effective communication<br />
tool when seeing other health professionals.<br />
National Health and Medical Research Council 111